Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Fluorodeoxyglucose F18 × Clear all

NCT02405078 2022-10-28

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase EARLY_PHASE1 Completed

Lymphoma, Large B-Cell, Diffuse

NCT01666353 2019-02-08

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Phase EARLY_PHASE1 Completed

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT01825902 2017-11-20

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Phase EARLY_PHASE1 Completed

Neuroectodermal Tumors, Primitive, Peripheral

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Phase EARLY_PHASE1 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00816335 2016-04-04

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific